US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Artelo Biosciences Inc (ARTL)
Artelo Biosciences Inc (ARTL) ニュース

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARTL

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/13	23 : 00	GlobeNewswire Inc.	Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12	NASDAQ:ARTL	Artelo Biosciences Inc
2024/12/09	23 : 15	GlobeNewswire Inc.	Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia	NASDAQ:ARTL	Artelo Biosciences Inc
2024/11/18	22 : 30	GlobeNewswire Inc.	Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit	NASDAQ:ARTL	Artelo Biosciences Inc
2024/11/13	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium	NASDAQ:ARTL	Artelo Biosciences Inc
2024/11/12	22 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2024/11/09	06 : 31	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ARTL	Artelo Biosciences Inc
2024/11/09	06 : 30	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ARTL	Artelo Biosciences Inc
2024/11/05	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program	NASDAQ:ARTL	Artelo Biosciences Inc
2024/10/09	22 : 00	GlobeNewswire Inc.	Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th	NASDAQ:ARTL	Artelo Biosciences Inc
2024/09/04	22 : 00	GlobeNewswire Inc.	Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:ARTL	Artelo Biosciences Inc
2024/08/13	21 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2024/07/15	21 : 30	GlobeNewswire Inc.	Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor	NASDAQ:ARTL	Artelo Biosciences Inc
2024/07/03	22 : 00	GlobeNewswire Inc.	Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium	NASDAQ:ARTL	Artelo Biosciences Inc
2024/07/02	22 : 00	GlobeNewswire Inc.	Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform	NASDAQ:ARTL	Artelo Biosciences Inc
2024/07/01	22 : 00	GlobeNewswire Inc.	Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium	NASDAQ:ARTL	Artelo Biosciences Inc
2024/06/04	21 : 30	GlobeNewswire Inc.	Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society	NASDAQ:ARTL	Artelo Biosciences Inc
2024/05/29	21 : 30	GlobeNewswire Inc.	Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24	NASDAQ:ARTL	Artelo Biosciences Inc
2024/05/13	21 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2024/05/10	22 : 00	GlobeNewswire Inc.	Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th	NASDAQ:ARTL	Artelo Biosciences Inc
2024/04/23	21 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy	NASDAQ:ARTL	Artelo Biosciences Inc
2024/04/22	21 : 30	GlobeNewswire Inc.	Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time	NASDAQ:ARTL	Artelo Biosciences Inc
2024/03/25	21 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2024/03/12	22 : 15	GlobeNewswire Inc.	Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge	NASDAQ:ARTL	Artelo Biosciences Inc
2024/01/23	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy	NASDAQ:ARTL	Artelo Biosciences Inc
2024/01/08	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12	NASDAQ:ARTL	Artelo Biosciences Inc
2023/12/05	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/30	23 : 00	GlobeNewswire Inc.	Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/13	22 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/13	22 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/09	23 : 00	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers	NASDAQ:ARTL	Artelo Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:ARTL

1 2 3 4 5 6 7 8 次へ >>

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

US Dollar vs Euro

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約